- Chart
- Upturn Summary
- Highlights
- Valuation
- About
PetMed Express Inc (PETS)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: PETS (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $2.75
1 Year Target Price $2.75
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -1.82% | Avg. Invested days 34 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 70.95M USD | Price to earnings Ratio - | 1Y Target Price 2.75 |
Price to earnings Ratio - | 1Y Target Price 2.75 | ||
Volume (30-day avg) 2 | Beta 0.66 | 52 Weeks Range 1.57 - 5.58 | Updated Date 01/9/2026 |
52 Weeks Range 1.57 - 5.58 | Updated Date 01/9/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.65 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -27.75% | Operating Margin (TTM) -16.13% |
Management Effectiveness
Return on Assets (TTM) -14.11% | Return on Equity (TTM) -78.89% |
Valuation
Trailing PE - | Forward PE 17.92 | Enterprise Value 35625809 | Price to Sales(TTM) 0.36 |
Enterprise Value 35625809 | Price to Sales(TTM) 0.36 | ||
Enterprise Value to Revenue 0.18 | Enterprise Value to EBITDA 0.63 | Shares Outstanding 21369521 | Shares Floating 13982600 |
Shares Outstanding 21369521 | Shares Floating 13982600 | ||
Percent Insiders 31.2 | Percent Institutions 35.29 |
Upturn AI SWOT
PetMed Express Inc

Company Overview
History and Background
PetMed Express Inc. was founded in 1996 as an independent online pet pharmacy. It aimed to provide a convenient and affordable way for pet owners to purchase prescription and non-prescription pet medications and supplies. Over the years, it has established itself as a significant player in the burgeoning online pet health market.
Core Business Areas
- Pet Medications: The primary business of PetMed Express is the sale of prescription medications for pets, including flea and tick preventatives, heartworm medications, antibiotics, and pain relievers. They operate as a licensed pharmacy and require veterinary prescriptions for these items.
- Pet Supplies: Beyond medications, PetMed Express also offers a range of pet supplies such as food, treats, vitamins, supplements, grooming products, and accessories.
- Customer Service and Convenience: A key aspect of their offering is the convenience of home delivery and auto-ship options for recurring medication needs.
Leadership and Structure
PetMed Express Inc. is a publicly traded company. As of recent filings, the company's leadership includes a CEO, CFO, and a Board of Directors. The organizational structure is typical for an e-commerce and pharmacy business, encompassing operations, marketing, customer service, and IT departments.
Top Products and Market Share
Key Offerings
- Product Name 1: Flea and Tick Preventatives: This category includes popular brands and generic options for protecting pets from common parasites. Competitors include major veterinary pharmaceutical companies and other online pet pharmacies. Market share data for specific product categories is not publicly disclosed in detail, but this is a significant revenue driver.
- Product Name 2: Heartworm Medications: Essential for pet health in many regions, these medications are a core offering. Competitors are similar to flea and tick preventatives, with major pharmaceutical companies dominating the branded product space.
- Product Name 3: Pain Management Medications: Prescription pain relievers for various pet conditions contribute to sales. This segment also faces competition from veterinary clinics and other online pharmacies.
Market Dynamics
Industry Overview
The pet industry, particularly the pet health and wellness sector, has shown consistent growth. Factors driving this growth include increased pet ownership, humanization of pets (treating pets as family members), and a willingness among owners to spend on their pets' health and well-being. The online retail segment for pet products is also expanding due to convenience and competitive pricing.
Positioning
PetMed Express Inc. is positioned as a leading online retailer of prescription pet medications and supplies in the United States. Its competitive advantages include a long-standing reputation, established customer base, and a focus on prescription fulfillment. However, it faces increasing competition from brick-and-mortar veterinary clinics, large online retailers with pet sections, and emerging direct-to-consumer pet health brands.
Total Addressable Market (TAM)
The total addressable market for pet medications and supplies in the U.S. is substantial and continues to grow, estimated to be tens of billions of dollars annually. PetMed Express Inc. holds a notable share of the online segment of this market, but the overall TAM also includes sales from veterinary clinics, which represent a significant portion of prescription medication sales.
Upturn SWOT Analysis
Strengths
- Established brand recognition and customer loyalty.
- Extensive experience in online pet pharmacy operations.
- Strong relationships with pharmaceutical suppliers.
- Convenient home delivery and auto-ship services.
- Broad product catalog including both prescription and OTC items.
Weaknesses
- Reliance on veterinary prescriptions, which can be a bottleneck.
- Increasing competition from veterinary clinics offering in-house pharmacies and direct sales.
- Potential for price competition from larger online retailers.
- Limited diversification beyond core pet medication and supply sales.
- Perceived by some as less personal than a local vet's office.
Opportunities
- Expansion of private label products.
- Partnerships with veterinary practices or pet insurance providers.
- Growth in the telehealth for pets market, which could drive prescription demand.
- Increasing demand for specialized pet diets and supplements.
- Further penetration into the non-prescription pet supply market.
Threats
- Regulatory changes affecting online pharmacies.
- Intensifying competition from both online and offline players.
- Potential for supply chain disruptions.
- Economic downturns affecting consumer discretionary spending on pets.
- Cybersecurity risks inherent in online retail and pharmacy operations.
Competitors and Market Share
Key Competitors
- Chewy Inc. (CHWY)
- Amazon.com Inc. (AMZN)
- Veterinary Clinics (various local and national networks)
Competitive Landscape
PetMed Express's advantage lies in its specialized focus on pet medications and its established pharmacy operations. However, it faces significant disadvantages in terms of scale and breadth of offerings compared to giants like Amazon and Chewy, which also offer a wider range of pet products and have massive customer bases. Veterinary clinics remain a formidable competitor for prescription sales due to the direct relationship and trust with pet owners.
Growth Trajectory and Initiatives
Historical Growth: Historically, PetMed Express experienced significant growth as an early mover in the online pet pharmacy space. This growth was fueled by the convenience factor and competitive pricing. However, recent years have seen challenges to this growth trajectory due to market saturation and increased competition.
Future Projections: Future projections are often influenced by analyst estimates, which would consider the company's ability to adapt to evolving market dynamics, manage competition, and innovate its product and service offerings. Analysts have shown mixed outlooks, with some projecting modest declines and others stable performance.
Recent Initiatives: Recent initiatives have likely focused on enhancing the customer experience, potentially exploring new product lines, improving marketing strategies, and optimizing operational efficiencies to counter competitive pressures. There has also been a focus on efforts to stabilize and potentially grow the business.
Summary
PetMed Express Inc. is a veteran online pet pharmacy facing intense competition in a growing market. Its strengths lie in its established brand and pharmacy expertise, while its weaknesses include limited scale and a reliance on prescriptions. Opportunities exist in product diversification and strategic partnerships, but threats from larger competitors and regulatory shifts require careful navigation. The company needs to innovate and adapt its strategy to regain growth momentum and solidify its market position.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Investor Relations Filings (e.g., SEC filings)
- Financial Data Providers (e.g., Refinitiv, Bloomberg)
- Industry Research Reports
- Company Website
Disclaimers:
This analysis is based on publicly available information and is intended for informational purposes only. It does not constitute investment advice. Financial data and market share figures are estimates and can change. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About PetMed Express Inc
Exchange NASDAQ | Headquaters Delray Beach, FL, United States | ||
IPO Launch date 1999-04-26 | Executive Chairman of the Board, Interim CEO & President Ms. Leslie C. G. Campbell | ||
Sector Healthcare | Industry Pharmaceutical Retailers | Full time employees 173 | Website https://www.1800petmeds.com |
Full time employees 173 | Website https://www.1800petmeds.com | ||
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

